Psychemedics Corp financial data

Symbol
PMD on Nasdaq
Industry
Services-Medical Laboratories
Location
125 Nagog Park, Acton, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 152 % -3.53%
Debt-to-equity 79.9 % +1.08%
Return On Equity -49.6 % -19.4%
Return On Assets -27.6 % -18.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.89M shares +1.6%
Common Stock, Shares, Outstanding 5.9M shares +1.6%
Entity Public Float 22.1M USD -17.8%
Common Stock, Value, Issued 32K USD 0%
Weighted Average Number of Shares Outstanding, Basic 5.89M shares +2.42%
Weighted Average Number of Shares Outstanding, Diluted 5.74M shares +2.03%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 855K USD -27.7%
Selling and Marketing Expense 2.68M USD -11.7%
General and Administrative Expense 7.16M USD +5.54%
Operating Income (Loss) -2.93M USD -21.7%
Nonoperating Income (Expense) -22K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.95M USD -0.96%
Income Tax Expense (Benefit) 43K USD -95.6%
Net Income (Loss) Attributable to Parent -3M USD +23.1%
Earnings Per Share, Basic -0.51 USD/shares +25%
Earnings Per Share, Diluted -0.68 USD/shares -94.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.41M USD +2.56%
Accounts Receivable, after Allowance for Credit Loss, Current 3.33M USD -27.7%
Assets, Current 6.05M USD -23.2%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 3.06M USD -33.1%
Operating Lease, Right-of-Use Asset 959K USD -53.6%
Other Assets, Noncurrent 505K USD -37.6%
Assets 9.84M USD -30.3%
Accounts Payable, Current 994K USD +21.7%
Accrued Liabilities, Current 1.82M USD -43.4%
Liabilities, Current 3.79M USD -29.6%
Deferred Income Tax Liabilities, Net 7K USD
Operating Lease, Liability, Noncurrent 535K USD -55.6%
Liabilities 4.39M USD -34.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.63M USD 0%
Retained Earnings (Accumulated Deficit) -18.8M USD -18.9%
Stockholders' Equity Attributable to Parent 5.45M USD -26.7%
Liabilities and Equity 9.84M USD -30.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -473K USD -110%
Net Cash Provided by (Used in) Financing Activities -75K USD -4.17%
Net Cash Provided by (Used in) Investing Activities 5K USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 6.56M shares +1.44%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -543K USD -46.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4K USD -20%
Deferred Tax Assets, Valuation Allowance 2.58M USD +188%
Deferred Tax Assets, Gross 3.52M USD +14.4%
Operating Lease, Liability 995K USD -56.1%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 2.07M USD -35.3%
Property, Plant and Equipment, Gross 2.24M USD -33.4%
Operating Lease, Liability, Current 460K USD -56.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 553K USD -47.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.06M USD -6.44%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 81K USD -65.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 460K USD -16.8%
Deferred Tax Assets, Operating Loss Carryforwards 87K USD +20.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 873K shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 460K USD -22.3%
Operating Lease, Payments 287K USD -1.38%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 944K USD -56.8%
Share-based Payment Arrangement, Expense 987K USD +9.79%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%